I want to
Before your invention goes public, fill out this simple technology disclosure form. It’s the straightforward, secure way to protect your hard work.
I want to
We have a massive database of innovative solutions that can give your company a competitive edge.
Expert industry advice and funding for commercially promising emerging technologies.
That’s you … and that’s us. WARF has been doing it for almost a century.
Chen to head biology for program aiming to produce preclinical candidates CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics, the multimillion-dollar…
Program proposal deadline October 8 CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics collaborates with researchers to advance their work closer…
Hongmin Chen's depth of translational experience and leadership qualities will help us drive projects to success and, ultimately, enable #WARFTherapeutics to deliver on our mission to advance solutions to patients. — @ErikIversonWARF
Hongmin Chen joins WARF Therapeutics - WARF
Chen to head biology for program aiming to produce preclinical candidates
www.warf.org
“WARF’s goal is to transfer ideas created on campus out into the world.” — @kevinawalters
#WisconsinInnovates
The storied history of scientific discovery at UW began over a century ago with the Babcock Butterfat Test. In this feature, Michaela Kihntopf guides us through other scientific breakthroughs that revolutionized our campus and the world. https://badgerherald.com/features/2021/09/20/century-of-discoveries-interconnected-tale-of-uws-most-innovative-research-epiphanies/
Happy National Postdoc Appreciation Day. Thank you to our UW–Madison postdocs for the vital role that they play in our University’s research enterprise. They enrich the academic environment and advance UW–Madison’s land grant mission and commitment to The Wisconsin Idea.
💊 Taxol = a reliable breast cancer drug that works for 50% of patients
🧪 @uwsmph @UWCarbone’s Beth Weaver = researcher trying to help make it 100
Breast cancer researchers learn how to teach an old drug new tricks to help patients
UW researchers have uncovered a key feature of breast cancers that renders them either vulnerable or resistant to paclitaxel treatment, which could he...
news.wisc.edu
New @UWMadison research reveals that metastatic prostate cancer comes in two forms, which respond differently to treatment. This knowledge could one day help doctors choose the best treatment for their patients.
Metastatic prostate cancer comes in two forms, which could guide treatment
The two subtypes respond differently — information that could one day help physicians match patients with the therapies best suited to their disease...
news.wisc.edu
